what is glp 1 peptide Glucagon-like in health and disease Glucagon-like peptide-1 receptor - Wikipedia

Nevertheless, it is increasingly evident that the antiinflammatory actions of GLP-1 and related mimetics represent key biological effects of agonizing the GLP-1 receptor, and these findings are considered to be of direct relevance to the renoprotective effects seen with GLP-1 mimetics

Figures based on published phase-3 trial data

For example, the SELECT trial showed a 20% improvement in major cardiovascular events (i.e., heart attacks, strokes, and deaths from those cases) in adults on weekly semaglutide who were overweight or obese (without diabetes) and with preexisting cardiovascular disease, as well as an improvement in all-cause mortality of 19%

To better illustrate the multifaceted nature of semaglutide-associated biological influences on sexual desire, we use Fig

These research efforts can prove the efficacy, safety, and real-world implications of GLP-1RAs as anti-inflammatory agents, ultimately informing treatment choices and improving patient care

In conclusion, GLP-1 receptor agonists are medications with a single mechanism of action, that is, they activate GLP-1 receptors at various organs, all of which contribute to weight loss